Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maureen Higgins

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
Drug Development Research|April 1, 2026
Novel Antioxidant Quinazoline Sulfonamide Derivatives Acting Through NQO1 Induction and Their Radiation-Based Biodistribution StudiesMostafa M Ghorab, Aiten M Soliman, Maureen Higgins, et al.
European Journal of Medicinal Chemistry|June 24, 2025
NQO1 induction and radiation-based biodistribution study of a new quinoline derivative identified in a screen of 6,8-diiodoquinazolinone sulfonamide conjugatesAiten M Soliman, Mostafa M Ghorab, Maureen Higgins, et al.
Journal of Natural Medicines|April 28, 2016
Potency of extracts from selected Egyptian plants as inducers of the Nrf2-dependent chemopreventive enzyme NQO1Ahmed R Hamed, Mohamed-Elamir F Hegazy, Maureen Higgins, et al.
The Journal of Biological Chemistry|December 10, 2020
Nrf2 is activated by disruption of mitochondrial thiol homeostasis but not by enhanced mitochondrial superoxide productionFilip Cvetko, Stuart T Caldwell, Maureen Higgins, et al.
Free Radical Biology & Medicine|September 9, 2022
Biotinylation of an acetylenic tricyclic bis(cyanoenone) lowers its potency as an NRF2 activator while creating a novel activity against BACH1Rita Moreno, Laura Casares, Maureen Higgins, et al.
Brain : a Journal of Neurology|March 15, 2018
KEAP1 inhibition is neuroprotective and suppresses the development of epilepsyTawfeeq Shekh-Ahmad, Ramona Eckel, Sharadha Dayalan Naidu, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 8, 2016
Whole-Exome Sequencing Validates a Preclinical Mouse Model for the Prevention and Treatment of Cutaneous Squamous Cell CarcinomaElena V Knatko, Brandon Praslicka, Maureen Higgins, et al.
Communications Biology|September 16, 2021
Nrf2 activation does not affect adenoma development in a mouse model of colorectal cancerElena V Knatko, Cecilia Castro, Maureen Higgins, et al.
Oncotarget|June 2, 2015
Redox effects and cytotoxic profiles of MJ25 and auranofin towards malignant melanoma cellsMarijke C C Sachweh, William C Stafford, Catherine J Drummond, et al.
Journal of Medicinal Chemistry|May 8, 2009
Novel cambinol analogs as sirtuin inhibitors: synthesis, biological evaluation, and rationalization of activityFederico Medda, Rupert J M Russell, Maureen Higgins, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Drug Development Research|April 1, 2026
Novel Antioxidant Quinazoline Sulfonamide Derivatives Acting Through NQO1 Induction and Their Radiation-Based Biodistribution StudiesMostafa M Ghorab, Aiten M Soliman, Maureen Higgins, et al.
European Journal of Medicinal Chemistry|June 24, 2025
NQO1 induction and radiation-based biodistribution study of a new quinoline derivative identified in a screen of 6,8-diiodoquinazolinone sulfonamide conjugatesAiten M Soliman, Mostafa M Ghorab, Maureen Higgins, et al.
Journal of Natural Medicines|April 28, 2016
Potency of extracts from selected Egyptian plants as inducers of the Nrf2-dependent chemopreventive enzyme NQO1Ahmed R Hamed, Mohamed-Elamir F Hegazy, Maureen Higgins, et al.
The Journal of Biological Chemistry|December 10, 2020
Nrf2 is activated by disruption of mitochondrial thiol homeostasis but not by enhanced mitochondrial superoxide productionFilip Cvetko, Stuart T Caldwell, Maureen Higgins, et al.
Free Radical Biology & Medicine|September 9, 2022
Biotinylation of an acetylenic tricyclic bis(cyanoenone) lowers its potency as an NRF2 activator while creating a novel activity against BACH1Rita Moreno, Laura Casares, Maureen Higgins, et al.
Brain : a Journal of Neurology|March 15, 2018
KEAP1 inhibition is neuroprotective and suppresses the development of epilepsyTawfeeq Shekh-Ahmad, Ramona Eckel, Sharadha Dayalan Naidu, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 8, 2016
Whole-Exome Sequencing Validates a Preclinical Mouse Model for the Prevention and Treatment of Cutaneous Squamous Cell CarcinomaElena V Knatko, Brandon Praslicka, Maureen Higgins, et al.
Communications Biology|September 16, 2021
Nrf2 activation does not affect adenoma development in a mouse model of colorectal cancerElena V Knatko, Cecilia Castro, Maureen Higgins, et al.
Oncotarget|June 2, 2015
Redox effects and cytotoxic profiles of MJ25 and auranofin towards malignant melanoma cellsMarijke C C Sachweh, William C Stafford, Catherine J Drummond, et al.
Journal of Medicinal Chemistry|May 8, 2009
Novel cambinol analogs as sirtuin inhibitors: synthesis, biological evaluation, and rationalization of activityFederico Medda, Rupert J M Russell, Maureen Higgins, et al.
Pageof 6